Compare AVAL & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVAL | TXG |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | Colombia | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.6B |
| IPO Year | 2011 | 2019 |
| Metric | AVAL | TXG |
|---|---|---|
| Price | $4.82 | $46.72 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 15 |
| Target Price | N/A | ★ $20.25 |
| AVG Volume (30 Days) | 134.0K | ★ 3.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $39.88 | N/A |
| Revenue Next Year | N/A | $7.33 |
| P/E Ratio | $12.86 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $2.80 | $11.17 |
| 52 Week High | $6.20 | $49.50 |
| Indicator | AVAL | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 67.66 |
| Support Level | $4.73 | $16.11 |
| Resistance Level | $4.98 | N/A |
| Average True Range (ATR) | 0.17 | 2.91 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 23.40 | 81.26 |
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management segment comprise administrator of pension and severance funds; and Holding segment.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).